10 Relapsing-Remitting Multiple Sclerosis (RRMS) Therapies

Click here to receive MS news via e-mail
news_16_Artboard 343 copy 166

Treating relapsing and remitting forms of multiple sclerosis requires a combination of cognitive and behavioral therapies, physiotherapy, lifestyle changes, and medication. Several pharmaceutical companies have clinical development plans in the works for the formulation of novel therapies to treat MS. Here are some of the available medications:

1. Aubagio (Oral)

news_16_Artboard 343 copy 156

Aubagio (chemically known as teriflunomide), marketed by Sanofi, is an active metabolite of the compound leflunomide and is a pyrimidine synthesis inhibitor.

Recently, researchers at the University of Texas Health Science Center at Houston, in collaboration with various institutions from north America and Europe, found that teriflunomide (Aubagio) is well-tolerated and efficient for the long-term treatment of multiple sclerosis (MS).

Read more about this study entitled “Long-term safety and efficacy of teriflunomide”.

Click here to receive MS news via e-mail

Leave a Comment

Your email address will not be published. Required fields are marked *